Invention Grant
- Patent Title: Manufacture of Degarelix
-
Application No.: US16947382Application Date: 2020-07-30
-
Publication No.: US11260102B2Publication Date: 2022-03-01
- Inventor: Grégoire Schwach , Anders Nilsson , Tine Elisabeth Gottschalk Bøving , Jon Holbech Rasmussen , Birgitta Mörnstam , Anders Tsirk , Ulf Annby , Jens Fomsgaard
- Applicant: Ferring B.V.
- Applicant Address: NL Hoofddorp
- Assignee: Ferring B.V.
- Current Assignee: Ferring B.V.
- Current Assignee Address: NL Hoofddorp
- Agency: Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
- Priority: EP12170454 20120601
- Main IPC: A61K9/19
- IPC: A61K9/19 ; A61K38/09 ; C07K7/06 ; A61K38/08 ; A61K38/25 ; A61K9/00 ; A61K47/26 ; A61K9/16 ; A61K47/12
Abstract:
The present invention provides methods for producing a lyophilized degarelix product which, upon reconstitution with water for injection in an amount of 20 mg/ml, shows a viscosity of up to 15 mPas. The present invention also provides a lyophilized degarelix drug substance which shows, upon dissolution in water in an amount of 20 mg/ml, a viscosity of up to 3.2 mPas, and processes for providing this lyophilized degarelix drug substance.
Public/Granted literature
- US20210077564A1 MANUFACTURE OF DEGARELIX Public/Granted day:2021-03-18
Information query
